Large holder update, amended
Open the filing on sec.gov
Penumbra, Inc. (PEN)
NYSE: PEN · Surgical & Medical Instruments & Apparatus · Alameda, CA · filing with the SEC since 2005
Grade7.0
◀ Past 6.6● Present 8.0▶ Future 6.0
The companyfiscal 2025, as filed
Revenue$1.40B+17.5%
Net income$178M+1168.1%
Earnings per share$4.52+1155.6%
Operating cash flow$239M+41.7%
Cash$187M-42.4%
Debtn/a
Shareholders’ equity$1.43B+24.0%
Shares, diluted39.3M+0.1%
Return on equity12.4%
The recordfrom its filings
Filings in 202663
Newest filingNov 6 · SCHEDULE 13G/A
Annual reportFeb 25, 2026
Quarterly reportOct 29, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$11.1M
Insider buys, 12 months$0.00
Patents granted72
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $1.56BNet income $157MCash from operations $261Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Large holder notice
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.